These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 21147094

  • 1. Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex.
    Ohoyama K, Yamamura S, Hamaguchi T, Nakagawa M, Motomura E, Shiroyama T, Tanii H, Okada M.
    Eur J Pharmacol; 2011 Feb 25; 653(1-3):47-57. PubMed ID: 21147094
    [Abstract] [Full Text] [Related]

  • 2. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
    Huang M, Panos JJ, Kwon S, Oyamada Y, Rajagopal L, Meltzer HY.
    J Neurochem; 2014 Mar 25; 128(6):938-49. PubMed ID: 24164459
    [Abstract] [Full Text] [Related]

  • 3. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.
    Amargós-Bosch M, Adell A, Artigas F.
    J Neurochem; 2007 Jul 25; 102(2):550-61. PubMed ID: 17394545
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T, Massari C, Graulich A, Liégeois JF, Tarazi FI.
    J Neurosci Res; 2006 Aug 15; 84(3):675-82. PubMed ID: 16810690
    [Abstract] [Full Text] [Related]

  • 5. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P, Nomikos GG, Svensson TH.
    Br J Pharmacol; 1997 Dec 15; 122(8):1639-46. PubMed ID: 9422809
    [Abstract] [Full Text] [Related]

  • 6. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T, Meltzer HY, Ichikawa J.
    J Pharmacol Exp Ther; 1999 Feb 15; 288(2):774-81. PubMed ID: 9918588
    [Abstract] [Full Text] [Related]

  • 7. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A, Díaz-Mataix L, Toth M, Celada P, Artigas F.
    Psychopharmacology (Berl); 2007 Apr 15; 191(3):745-58. PubMed ID: 17265076
    [Abstract] [Full Text] [Related]

  • 8. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z, Huang M, Prus AJ, Dai J, Meltzer HY.
    Brain Res; 2007 Feb 23; 1134(1):70-8. PubMed ID: 17207474
    [Abstract] [Full Text] [Related]

  • 9. Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons.
    Katz NS, Guiard BP, El Mansari M, Blier P.
    J Psychopharmacol; 2010 Aug 23; 24(8):1223-35. PubMed ID: 19939862
    [Abstract] [Full Text] [Related]

  • 10. Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist.
    Ohno Y, Okano M, Imaki J, Tatara A, Okumura T, Shimizu S.
    Pharmacol Biochem Behav; 2010 Aug 23; 96(2):175-80. PubMed ID: 20460137
    [Abstract] [Full Text] [Related]

  • 11. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A.
    Brain Res Bull; 2006 Mar 31; 69(2):204-13. PubMed ID: 16533671
    [Abstract] [Full Text] [Related]

  • 12. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
    Auclair A, Blanc G, Glowinski J, Tassin JP.
    J Neurochem; 2004 Oct 31; 91(2):318-26. PubMed ID: 15447665
    [Abstract] [Full Text] [Related]

  • 13. Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.
    Hertel P, Nomikos GG, Schilström B, Arborelius L, Svensson TH.
    Neuropsychopharmacology; 1997 Jul 31; 17(1):44-55. PubMed ID: 9194049
    [Abstract] [Full Text] [Related]

  • 14. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile.
    Millan MJ, Gobert A, Newman-Tancredi A, Lejeune F, Cussac D, Rivet JM, Audinot V, Adhumeau A, Brocco M, Nicolas JP, Boutin JA, Despaux N, Peglion JL.
    J Pharmacol Exp Ther; 2000 Jan 31; 292(1):38-53. PubMed ID: 10604930
    [Abstract] [Full Text] [Related]

  • 15. The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex.
    Pira L, Mongeau R, Pani L.
    Eur J Pharmacol; 2004 Nov 03; 504(1-2):61-4. PubMed ID: 15507222
    [Abstract] [Full Text] [Related]

  • 16. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
    Liégeois JF, Deville M, Dilly S, Lamy C, Mangin F, Résimont M, Tarazi FI.
    J Med Chem; 2012 Feb 23; 55(4):1572-82. PubMed ID: 22268448
    [Abstract] [Full Text] [Related]

  • 17. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P, Flore G, Pira L, Diana M, Gessa GL.
    Psychopharmacology (Berl); 2002 Mar 23; 160(2):220-4. PubMed ID: 11875641
    [Abstract] [Full Text] [Related]

  • 18. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.
    López-Gil X, Artigas F, Adell A.
    Int J Neuropsychopharmacol; 2009 May 23; 12(4):487-99. PubMed ID: 18752722
    [Abstract] [Full Text] [Related]

  • 19. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z, Ichikawa J, Dai J, Meltzer HY.
    Eur J Pharmacol; 2004 Jun 16; 493(1-3):75-83. PubMed ID: 15189766
    [Abstract] [Full Text] [Related]

  • 20. Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex.
    Yamamura S, Ohoyama K, Hamaguchi T, Kashimoto K, Nakagawa M, Kanehara S, Suzuki D, Matsumoto T, Motomura E, Shiroyama T, Okada M.
    Psychopharmacology (Berl); 2009 Oct 16; 206(2):243-58. PubMed ID: 19575183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.